Skinvisible Signs Deal with Embil

Skinvisible, Inc., Las Vegas, has signed an exclusive licensing agreement with Embil Pharmaceutical Co. Ltd. The agreement is for the right to develop and market two of Skinvisible’s prescription anti-acne products formulated with Invisicare and the active ingredients Clindamycin HCL, and retinoic acid. Invisicare is Skinvisible’s patented polymer delivery technology that is said to provide many benefits to topically delivered products including binding to the skin for four hours or more, resisting wash-off, decreased irritation and sustained release. Along with these benefits, Invisicare provides pharmaceutical companies with product life-cycle management for their branded products coming off patent by adding value and new patent protection, according to Skinvisible.

This agreement with Embil, a multinational dermatology company based in Istanbul, Turkey, is Skinvisible’s second entry into the $2.8 billion acne market. The territory includes Turkey, Azerbaijan, Kazakhstan, Kyrgyzstan, Turkmenistan, and Uzbekistan, as well as Indonesia, Malaysia, and the Philippines where Embil will seek marketing approval. This agreement, brought to Skinvisible by Riley-Nacht, LLC, one of our marketing partners, gives Embil the right to manufacture, distribute and market these acne formulations in a dual chamber device in the territory specified above. Skinvisible will receive a development fee, a license fee allocated in milestone payments as well as royalties based on product sales.

“Skinvisible has now formulated and licensed three key acne products; Adapalene, Clindamycin HCL and retinoic acid,” said  Terry Howlett, president  and CEO of Skinvisible. “This new agreement shows that we continue to remain focused on our strategic plan to expand and license our patented product offerings around the world and we are very encouraged by the interest in these three acne products outside of the territories already signed.”

Skinvisible is also seeking to license its portfolio of over 25 topical dermatology products formulated with Invisicare including prescription and over-the-counter products for the treatment of atopic dermatitis, fungal infections, anti-inflammatories, as well as hand sanitizers, anti-aging, analgesic and sunscreen products.